tldrdaily.news logo

Drugmaker slashes US price of weight-loss therapy

1 min read
Source: Financial Times
Drugmaker slashes US price of weight-loss therapy
Photo: Financial Times
TL;DR Summary

Novo Nordisk has halved the US price of its weight‑loss drug, a move aimed at broadening access amid strong demand and competition in the GLP‑1 market.

Topics:business#business#novo-nordisk#pharmaceutical-pricing#price-cut#us-price#weight-loss-drug
Share this article
  1. Novo Nordisk halves US price of weight-loss drug  Financial Times
  2. Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients  CNBC
  3. Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy  MarketWatch
  4. Novo Nordisk cuts sticker price of weight-loss drugs  Axios
  5. Novo to cut Ozempic and Wegovy prices amid intense competition  USA Today

Reading Insights

Total Reads

0

Unique Readers

2

Time Saved

4 min

vs 4 min read

Condensed

97%

766 → 26 words

Want the full story? Read the original article

Read on Financial Times